MoBiTec GmbH to Attend LABVOLUTION/ BIOTECHNICA, May 16-18, 2017, Hannover, Germany

LABVOLUTION with BIOTECHNICA is a fully integrated event that provides a multidisciplinary perspective on all aspects of the laboratory world. Don't miss Northern Europe's leading business platform for laboratory technology and biotechnology. - March 31, 2017 - MoBiTec GmbH

Jivana Biotechnology Inc, is Pleased to Announce the Addition of Dr. Ajay Maker to Its Advisory Committee

Jivana Biotechnology Inc, is Pleased to Announce the Addition of Dr. Ajay Maker to Its Advisory Committee

Dr. Maker brings surgical oncology experience with expertise in liver, gallbladder. colon, pancreatic, and other cancers to Jivana Biotechnology's advisory committee. - March 16, 2017 - Jivana Biotechnology Inc

AdvantaPure(R) Launches AdvantaSil(TM) Brand of Silicone Tubing and Hose

AdvantaPure has rebranded its silicone tubing and reinforced hose under the AdvantaSil name. The products, used primarily for biopharm and pharmaceutical Single-Use processes, have been depended upon by design engineers for years. AdvantaSil products include unreinforced tubing, reinforced hose, pump grade tubing and wire reinforced suction hose. - March 16, 2017 - AdvantaPure

Novel Lipid Research Assay: Lysosomal PLA2 Inhibitor Screen

Inhibition of Lysosomal phospholipase A2 (LPLA2) by a drug candidate can predict its potential to cause drug-induced phospholipidosis, a serious side effect resulting in tissue inflammation and organ damage. - March 11, 2017 - MoBiTec GmbH

Kemwell Announces Successful USFDA Inspection at Bangalore Facility

Kemwell Announces Successful USFDA Inspection at Bangalore Facility

Kemwell Biopharma, a global bio/pharmaceutical contract development and manufacturing company, announced today that its oral solids manufacturing facility located in Bangalore, India has successfully completed a U.S. Food and Drug Administration (USFDA) inspection. The inspection confirmed the... - February 19, 2017 - Kemwell Biopharma Private Limited

Virun® Releases STATIC™ Episode 2 While Under the Influence of Sulfur Hexaflouride, and New Probiotic Technology Makes Wholefoods Take Notice

Virun® Releases STATIC™ Episode 2 While Under the Influence of Sulfur Hexaflouride, and New Probiotic Technology Makes Wholefoods Take Notice

Virun® NutraBiosciences® Ongoing Video Series Explores the Smells of Stability and Voice-changing Gases; Virun’s Patent & Patents-pending Non-refrigerated Shelf-stable Probiotics Become Available to Manufacturers Worldwide - February 14, 2017 - VIRUN

NuvOx Pharma and Jiangsu Nhwa Pharmaceutical Co., Ltd. Sign Licensing Agreement for Hemorrhagic Shock and Perioperative Blood Loss

NuvOx Pharma LLC and Jiangsu Nhwa Pharmaceutical Co., Ltd. have signed a licensing agreement for the exclusive development and sales of NVX-408 for China for treating hemorrhagic shock and perioperative blood loss. NVX-408 is an oxygen therapeutic that is injected intravenously, flows through the... - January 26, 2017 - NuvOx Pharma

The Zoozler Venture Network is Looking for an Idea

You have a fantastic idea for a product or service but you don't know how to go about making it a reality. You know that you'll need investors but how do you get to them? That's where the Zoozler Venture Network can help. The Zoozler Venture Network will take the idea and help make it into a successful reality. - January 13, 2017 - Zoozler

Life Science Leader and ClinicalLeader.com Announce New Forum for Small to Mid-Sized Pharma and Biotech Companies

Life Science Leader and ClinicalLeader.com are excited to introduce Clinical Leader Forum, a new conference tailored just for executives at pharma and biotech sponsor companies that rely on contract research organizations for clinical trials. The inaugural event is scheduled for May 10 through 11... - December 07, 2016 - Clinical Leader Forum

New Research Explores Wearable Technology Utilization in Clinical Trials and the Role of CROs

New Report Identifies Current and Future Wearable Technology Utilization and CRO Implications with 130 Clinical Outsourcing Decision Makers. - December 01, 2016 - Life Science Strategy Group, LLC

Research to be Presented at ASH Annual Meeting Shows Verseon’s New Class of Anticoagulants Prevents Thrombosis While Preserving Platelet Function

Verseon’s anti coagulants are as effective as NOACS at preventing arterial and venous thromboembolism and thrombin-induced pulmonary embolism. Lead candidate has low renal clearance compared to NOACS - highly desirable for patients with impaired renal function. - November 30, 2016 - Verseon

Gensco Pharma Announces ColciGel®, a New Transdermal Medication Indicated for the Treatment of Acute Gout Flares in Adults

Gensco Pharma Announces ColciGel®, a New Transdermal Medication Indicated for the Treatment of Acute Gout Flares in Adults

A new transdermal gel has been developed and is now available by prescription only to treat the symptoms of gout attacks. ColciGel® is a transdermal medication that provides rapid relief of pain at the first sign of acute gout flares without gastrointestinal problems. - November 22, 2016 - Gensco Pharma

Astero®, Manufactured by Gensco Laboratories, is the Only FDA Approved Prescription Hydrogel with Topical Anesthetic, Indicated for Painful Wounds

Astero®, Manufactured by Gensco Laboratories, is the Only FDA Approved Prescription Hydrogel with Topical Anesthetic, Indicated for Painful Wounds

Astero® is indicated for painful wounds such as stage I-IV pressure ulcers, Venous stasis ulcers, ulcerations caused by mixed vascular etiologies, Diabetic skin ulcers, first and second degree burns, post-surgical incisions, cuts and abrasions. Astero® is specifically formulated to create a moist healing environment, which promotes granulation, epithelialization, and autolytic debridement, while providing prolonged anesthesia of the wound, lessening the need for systemic pain medications. - November 19, 2016 - Gensco Pharma

Virun® Launches a Line of Shelf-Stable Probiotic Multi-Serving Powders and Emulsions

Virun® Launches a Line of Shelf-Stable Probiotic Multi-Serving Powders and Emulsions

Virun® NutraBiosciences® Technology Revolutionizes Probiotics with Non-refrigerated Probiotic Single-serving Powders and Emulsions Available to Manufacturers. - November 15, 2016 - VIRUN

NuvOx Pharma Awarded NIH Grant to Develop Technology to Increase Sensitivity and Specificity of Breast Cancer Diagnosis

NuvOx Pharma, a Tucson based biotechnology company, has been awarded a grant from the National Cancer Institute for $298,820.00 entitled, “B7-H3-Targeted Contrast Agent for Ultrasonic Imaging of Breast Cancer.” Evan Unger, MD, co-founder of NuvOx, a co-principal investigator of the... - November 03, 2016 - NuvOx Pharma

New Research Benchmarks Clinical Investigator Satisfaction with Pharma Sponsors and Central Laboratories

5-year Study Tracks Central Lab Performance and Identifies Opportunities for Pharma Sponsors to Improve Clinical Investigator Satisfaction. - October 24, 2016 - Life Science Strategy Group, LLC

Experimentica Ltd. Appoints New Director of In Vivo Pharmacology

Experimentica Ltd., a global ophthalmic contract research organization (CRO) today announced the appointment of Tamuna Bolkvadze, Ph.D. to Director In Vivo Pharmacology, effective immediately. Dr. Bolkvadze joined Experimentica Ltd. earlier in 2016 as Research Scientist and has been instrumental... - October 22, 2016 - Experimentica Ltd

Spherium Biomed Starts Efficacy Trial Cyclatop for the Treatment of Atopic Dermatitis in Adults and Infants

The clinical trial is a pilot study (the Cyclatop study) for the evaluation of SP14019-F-01 topical solution for the treatment of atopic dermatitis. It is designed to investigate the safety, tolerability, pharmacokinetics and efficacy of SP14019-F-01 across all group ages for the treatment of mild... - September 29, 2016 - Spherium Biomed

STATIC™ – New Video Broadcast Series Uncovering “The Good, The Bad and the Ugly” of Nutritional Products

STATIC™ – New Video Broadcast Series Uncovering “The Good, The Bad and the Ugly” of Nutritional Products

Virun® Nutra-BioSciences® Creates New Series of Video Broadcasts Called STATIC, Focusing on Nutrition Found in Finished Products. - September 27, 2016 - VIRUN

Quorum Innovations Announces Availability of Human Microbiome Therapeutics to Treat Common Skin Conditions and Metabolic Disorders

Probiomic Therapeutics™ for Eczema, Atopic Dermatitis, Eosinophilic Esophagitis (EoE), Metabolic Disorders - September 24, 2016 - Quorum Innovations

AUM LifeTech's Self-Delivering FANA Antisense Oligonucleotides to be Distributed by MoBiTec Germany

AUMsilence self-delivering oligos achieve highly efficient and potent antisense-based gene knockdown. No need to use toxic transfection reagents. Especially designed for primary cells and very difficult-to-transfect cell types. - September 24, 2016 - MoBiTec GmbH

For Lentivirus Production: TransIT®-Lenti Transfection Reagent, Available from MoBiTec, Germany

TransIT®-Lenti Transfection Reagent, manufactured by Mirus Bio, US, is designed to enhance delivery of packaging and transfer vectors to adherent HEK 293T cell types and increase recombinant lentivirus production. - September 23, 2016 - MoBiTec GmbH

Batavia Biosciences Receives Grant to Develop New Vaccine Against Rotavirus

Batavia Biosciences received an $8 million grant from the Bill & Melinda Gates Foundation to develop a low cost manufacturing process to bring an affordable rotavirus vaccine to the global health market. This vaccine aims to save many young children’s lives worldwide. - September 21, 2016 - Batavia Biosciences

We All Want to Live in a Yellow Submarine at Virun’s SupplySide West Booth

We All Want to Live in a Yellow Submarine at Virun’s SupplySide West Booth

Go under the sea in a yellow submarine and cast your vote for the next Omega-3 Smoothie - September 15, 2016 - VIRUN

Recursion Pharmaceuticals Receives Fast-Track SBIR Grant to Study Age-Related Disease

Recursion Pharmaceuticals, an exciting biotech company located in the University of Utah’s Research Park, today announced a $223,000 Phase I Small Business Innovation Research award from the National Institutes of Health (NIH) via the National Institute on Aging (NIA). The award, which has... - September 15, 2016 - Recursion Pharmaceuticals

CHI's 8th Annual SCOPE: Summit for Clinical Ops Executives Returns to Miami, January 24-26, 2017

1,200+ Executives to gather for solutions on various aspects of clinical trial planning and management at 13 co-located conferences and 2 symposia - September 13, 2016 - Cambridge Healthtech Institute

CRISPR/Cas9 - Request a Free Sample for Your Genome Editing Research

The use of CRISPR/Cas9 has emerged as a powerful method for genome editing that can be delivered in multiple formats. MoBiTec together with Mirus Bio provide solutions to address delivery of Cas9 and guide RNA in plasmid, RNA, or RNP format. - September 10, 2016 - MoBiTec GmbH

Silicone Suction Hose from AdvantaPure(R) is Now NSF Listed; Provides an Increased Level of Quality Assurance

AdvantaPure’s APSW silicone suction hose now boasts an NSF listing (NSF-51), giving users reassurance for the product’s compatibility with food, beverage and other clean applications. APSW is reinforced with a helical stainless steel wire and layers of fabric and silicone to handle both suction and discharge applications. The hose is available in smooth or convoluted O.D. styles, withstands temperatures up to 350 degrees F, and may be sterilized using several different methods. - September 02, 2016 - AdvantaPure

Dextra UK Launched the World's Largest Commercial Glycan Array, Marketed in Germany and Other Countries Through Its Authorized Distributor MoBiTec GmbH

Dextra's Glycan Array Kit is a valuable tool for use in determining the glycan binding profile of proteins, eukaryotic cells, viruses, spores, bacteria, and parasites. It features 104 unique glycans carefully selected from cutting-edge libraries. - September 02, 2016 - MoBiTec GmbH

NuvOx Pharma Awarded NIH Grant to Develop Technology to Treat Endocarditis

NuvOx Pharma, a Tucson based biotechnology company, has been awarded a grant from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) of the National Institutes of Health for $243,164.00 entitled, “Fibrin Targeted Microbubbles and Ultrasound for... - August 27, 2016 - NuvOx Pharma

PBTF Unites with We Can to Form California Chapter

The We Can Pediatric Brain Tumor Network is now the California Chapter of the Pediatric Brain Tumor Foundation. - August 25, 2016 - Pediatric Brain Tumor Foundation

FDA Allows NuvOx Pharma’s IND to Initiate Phase Ib Clinical Trial in Stroke

Evan Unger, MD, President and CEO of NuvOx, announced that the FDA has allowed an investigational new drug application (IND) for NVX-208 (dodecafluoropentane emulsion) to be tested in a Phase Ib trial in stroke patients. The trial will be performed at the University of Arkansas Medical System in... - August 22, 2016 - NuvOx Pharma

MiTeGen Awarded 2016 Inc. 5000 Recognition

MiTeGen LLC, a provider of innovative consumables for protein crystallization and X-ray diffraction to academic, pharmaceutical, industrial and government researchers around the world, has been awarded a listing on the 2016 Inc. 5000. The Inc.5000 recognizes the country's top 5000 fastest-growing private companies. - August 18, 2016 - MiTeGen, LLC

KinderPharm to Celebrate Grand Opening of New Exton Office

Pennsylvania Elected Officials to Participate in Ribbon-Cutting Ceremony and Grand Opening Event; KinderPharm is pleased to announce that it will hold a Grand Opening event and Ribbon-Cutting ceremony for its new office at 100 Arrandale Blvd., Exton, Pennsylvania on Friday, August 26th from 1 p.m. to 3 p.m. The event will feature a ribbon-cutting ceremony at 1 p.m., food and refreshments, and industry networking. - August 16, 2016 - KinderPharm LLC

Titanium Healthcare, Inc. Provides Update Regarding Current Ventures

Titanium Healthcare, Inc. (OTCQB: TIHC) ("Titanium") today announced the following updates: Odin Titanium previously announced the formation of Odin Applied Research Laboratories (“OARL”) to conduct a joint venture with Odin Industries, LLC. On September 11, 2015. The closing... - August 01, 2016 - Titanium Healthcare, Inc

Titanium Healthcare, Inc. Provides Update Regarding Annual 10K Report

Titanium Healthcare, Inc. (OTCQB: TIHC) ("Titanium") today announced that the continued delay in the filing of the Company's annual report on Form 10-K, which was due on April 15, 2016, is due to the challenges surrounding the following, which management has been addressing: -Recent... - July 31, 2016 - Titanium Healthcare, Inc

Fluorescent Cell Organelle Stains - Free Brochure Launched by MoBiTec GmbH

Fluorescent molecules and conjugates are invaluable tools in modern medical and biological laboratories. Cell-permeant fluorophores help reveal the localization of intracellular organelles and structures in live cells with minimal impairment. - July 30, 2016 - MoBiTec GmbH

Braincure Biotech Study Indicates New Target for Combating Alzheimer’s

A team of researchers led by Sírnir Thorsson has established that the protein GPR3 could be instrumental in relieving cognitive deficits and mitigating the production of "amyloid plaques." - July 21, 2016 - BrainCure Biotech

Braincure Biotech Publishes Two New Reports

With more than 90 medicines in clinical trials or awaiting approval and knowledge of Alzheimer’s increasing, patients and caretakers look towards the future with high spirits. - July 21, 2016 - BrainCure Biotech

MiTeGen Announces NANUQ™, an Automated High-Speed Cryocooling Device

MiTeGen LLC, a provider of innovative consumables for protein crystallization and X-ray diffraction to academic, pharmaceutical, industrial and government researchers around the world, announced the launch of their NANUQ™ automated, high-speed, cryocooling device for improved cryopreservation of small samples. - July 20, 2016 - MiTeGen, LLC

MiTeGen Announces Sentinel™, Real-Time Intensity Monitoring Beamstop System

MiTeGen LLC, a provider of innovative consumables for protein crystallization and X-ray diffraction to academic, pharmaceutical, industrial and government researchers around the world, announced the launch of their Sentinel™ Real-time Intensity Monitoring Beamstop Systems for X-ray beamlines. - July 15, 2016 - MiTeGen, LLC

AdvantaPure(R) Releases Its Schedule of Trade Show Appearances for Summer and Fall 2016; Includes Events in the US and Asia

AdvantaPure, the high-purity division of plastic tubing manufacturer NewAge Industries, will exhibit at shows in Taiwan, Massachusetts and China over the next several months. The shows will focus on biopharmaceutical and pharmaceutical equipment and processes. AdvantaPure will highlight its products that meet those processing needs, such as Single-Use tubing, process hose, leak-proof molded manifold assemblies, container closures, and wall pass-through systems. - July 15, 2016 - AdvantaPure

Trial Runners LLC is a “Great Place To Work®”

Trial Runners was certified as a great workplace today by the independent analysts at Great Place to Work®. Trial Runners earned this credential based on extensive ratings provided by its employees in anonymous surveys. - July 13, 2016 - Trial Runners

Quantgene Achieves Breakthrough in Liquid Biopsy Early Cancer Detection by Combining Machine Learning with Next-Generation PCR

Quantgene announced a breakthrough in early cancer detection with a new approach to detect tumor DNA in standard blood samples that combines proprietary machine learning algorithms with next-generation polymerase chain reaction (PCR) technology. The Quantgene researchers analyzed large sets of... - July 08, 2016 - Quantgene

MiTeGen Announces Expansion of Manufacturing and R&D Facilities

MiTeGen LLC, a provider of innovative consumables for protein crystallization and X-ray diffraction to academic, pharmaceutical, industrial and government researchers around the world, announced facility expansions which include space for manufacturing of a new line of automated high-speed cryocooling devices, as well as dedicated areas for the manufacturing of CrystalDirect™ crystallization plates. - June 29, 2016 - MiTeGen, LLC

Virun® Receives U.S. Patent 9,351,517 for Its Vitamin E, Esolv®, All-the-While Rebranding Itself as a Notable Formulation and Development Giant

Virun® Receives U.S. Patent 9,351,517 for Its Vitamin E, Esolv®, All-the-While Rebranding Itself as a Notable Formulation and Development Giant

Soon after international patent approval, Virun receives U.S. patent 9,351,571 for its principle technology, Esolv®. As research continues to show oils, fats and non-polar compounds have strong and growing efficacious health claims, the need to incorporate these compounds into foods, beverages and supplements will become even more sought-after. VIRUN’s extensive Portfolio, including Esolv®, is accelerating innovation. What Virun has created is notably notable in a noticeable way. - June 16, 2016 - VIRUN

AdvantaPure(R) Offers a New White Paper Focusing on Molded Tubing Connections; Illustrates the Risks and Expenses of Fluid Leaks in Biopharma Manufacturing Operations

Immediately available from high purity tubing manufacturer AdvantaPure is a report titled “How Molded Manifold Assemblies Prevent Leaks and Costly Consequences.” It addresses the risks and costs associated with tubing-to-fitting connection leaks and presents a solution, namely the use of molded connections. The white paper shows how critical leak risk becomes based on the number of connections in a manifold assembly. Additional white papers are available as well. - June 16, 2016 - AdvantaPure

ValueTrak 8.0 Release Re-Imagines Fee-for-Service Scorecarding with New Data Quality Metrics and Robust Customization Capabilities

ValueCentric, the industry leader in healthcare channel intelligence, announced enhancements to their Scorecard capabilities as part of ValueTrak 8.0 software release. Improvements include advanced Specialty and Channel Data Management metrics, integrating data completeness, timeliness, and... - June 15, 2016 - ValueCentric

South Korea Patent Allowance for Anti-Obesity Pet Vaccines to Braasch Biotech LLC

Braasch Biotech granted Anti-Obesity patent for pets by Korean Intellectual Property Office. Commercial utility and novelty for first therapeutic vaccine for use in obese dogs, cats and horses. - June 11, 2016 - Braasch Biotech LLC

Theater Slim PCR Cycler - Small Footprint, Small Price, Great Flexibility

MoBiTec is selling an incredibly small, light, and slim (4 cm), yet fully functional PCR instrument - The Theater Slim PCR Cycler. It is beneficial to small-sized labs and in-the-field research. - June 01, 2016 - MoBiTec GmbH

Press Releases 351 - 400 of 1,342